We need the push for local trials to come to fruition…this looks on track partnering locally with Cell Therapies.
Rebecca now needs to partner with local government for trial funding and local universities
It’s ambitious but a local cell therapies ecosystem should be fostered with partnerships between private companies, universities and governments.
CHM could do with some grant funding to help get further down the track and prove Rebecca is the right fit and obtain the non-dilutional funding she has been speaking about . This will provide a base level
of funding to progress the pipeline while contributing to the local cell therapy network.
good for CHM, Australia and patients.
Management are only really responsible for funding at the moment while the science progresses to then allow them to commercialise.
it’s all been dilutional funding to this point apart from the RnD rebates. We need more than this.
- Forums
- ASX - By Stock
- Chimeric: Media Thread
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

We need the push for local trials to come to fruition…this looks...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $69.79K | 17.44M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
40 | 26298938 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 9548289 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
40 | 26298938 | 0.003 |
16 | 13800507 | 0.002 |
10 | 50600000 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 9548289 | 12 |
0.005 | 14771167 | 22 |
0.006 | 13747410 | 16 |
0.007 | 4700000 | 4 |
0.008 | 8542434 | 6 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online